ACVR2A HEK-293(ACVR2B KO) Cell Line
Stable monoclonal cell line with ACVR2A overexpression constructed using lentiviral technology based on HEK-293(ACVR2B KO) cells.
本分类收录的细胞产品与配套技术资料,支持按来源、物种与规格筛选。 共 198 个产品。
Stable monoclonal cell line with ACVR2A overexpression constructed using lentiviral technology based on HEK-293(ACVR2B KO) cells.
A stable monoclonal cell line with ACVR2A knockout was established using lentiviral technology based on HEK-293 cells.
Stable monoclonal cell line with ACVR2B overexpression constructed using lentiviral technology based on HEK-293(ACVR2A KO) cells.
Stable monoclonal cell line with ACVR2B knockout constructed using lentiviral technology based on HEK-293 cells.
AR Knockout 293T Cell Line by ImmunoClone provides essential androgen receptor pathway analysis for prostate cancer and endocrine disorder research.
ATP7B Knockout 293T Cell Line provides a reliable model for studying copper metabolism dysregulation and Wilson's disease pathogenesis mechanisms.
Axin1 Knockout 293T Cell Line by ImmunoClone offers Wnt/β-catenin pathway disruption for cancer research and developmental biology applications.
B2M Knockout THP-1 Cell Line by ImmunoClone provides an MHC class I-deficient human monocyte model for immunotherapy and immune evasion mechanism studies.
B2M/CIITA Double Knockout THP-1 Cell Line creates an MHC I/II-deficient human macrophage model for advanced immunotherapy and immune evasion research.
Bak Knockout 293T Cell Line by ImmunoClone offers reliable modeling of apoptosis resistance and mitochondrial death pathway dysfunction mechanisms.
Bax Knockout 293T Cell Line by ImmunoClone provides a key model for studying mitochondrial apoptosis pathways and chemotherapy resistance mechanisms.
BCMA Knockout RPMI-8226 Cell Line by ImmunoClone provides a key model for studying multiple myeloma resistance mechanisms and antibody therapy development.
BCMA Knockout RPMI-8226/Luciferase Cell Line by ImmunoClone enables dual-mode myeloma studies with BCMA signaling research and bioluminescent tumor tracking.
CD19 Knockout Raji Cell Line by ImmunoClone facilitates efficient CAR-T cell therapy validation and B-cell receptor signaling disruption investigations.
CD19 Knockout Raji/Luciferase Cell Line by ImmunoClone provides a validated model for investigating antigen escape in diffuse large B-cell lymphoma research.
CD19/CD20 Double Knockout Raji Cell Line by ImmunoClone enables precise evaluation of B-cell depletion therapies and combination immunotherapy mechanisms.
CD19/CD20 Double Knockout Raji/Luciferase Cell Line provides a validated dual-knockout model for CAR-T and bispecific antibody therapy development.
CD20 Knockout Raji Cell Line by ImmunoClone is optimized for anti-CD20 drug development and B-cell signaling studies in lymphoma research applications.
CD20 Knockout Raji/Luciferase Cell Line provides a bioluminescent CD20-deficient model for evaluating CD19-targeting therapies and CAR-T cell efficacy.
CD36 Knockout THP-1 Cell Line by ImmunoClone provides a validated model for studying lipid metabolism, inflammation, and phagocytosis in macrophages.
A monoclonal cell line stably expressing CD47 PDL1 constructed using viral technology based on MC38 cells.
CD63 Knockout 293T Cell Line by ImmunoClone enables essential research on exosome biogenesis, tetraspanin networks, and immune synapse formation.
CDH1 Knockout 293T Cell Line by ImmunoClone provides an essential model for studying epithelial-mesenchymal transition (EMT) and cancer metastasis mechanisms.
CHD1 Knockout 293T Cell Line by ImmunoClone provides an essential tool for chromatin remodeling research and prostate cancer development studies.
共 198 个产品 | 第 1 / 9 页